Get Instant Summarized Text (Gist) Early use of an intra-aortic balloon pump (IABP) in patients with cardiogenic shock due to heart failure did not improve 60-day survival or facilitate transition ...

Compared with standard medical care, early use of a temporary intra-aortic balloon pump (IABP) to support heart function in patients who were critically ill with cardiogenic shock caused by heart ...

Compared with standard medical care, early use of a temporary intra-aortic balloon pump (IABP) to support heart function in patients who were critically ill with cardiogenic shock caused by heart ...

Leveraging the patented technology of the AC3 Optimus™ IABP, the AC3 Range™ IABP is designed to provide reliable, ongoing IABP support across various patient transport modes, including ...

The Guam Memorial Hospital Authority said its acquisition of its first-ever intra-aortic balloon pump is a significant advancement that will transform cardiac care on the island. The state-of-the ...

(European Heart Journal) In heart failure complicated by cardiogenic shock, early intra-aortic balloon pump (IABP) placement did not help clinical outcomes in the small randomized trial Altshock-2.

The IABP, developed in the 1960s, was the first device to provide temporary mechanical support to the heart in patients with cardiogenic shock, Sacco said. Although other such devices have been ...

(RTTNews) - Teleflex (TFX) announced FDA 510(k) clearance of the AC3 Range Intra-Aortic Balloon Pump. The AC3 Range IABP is designed to provide ongoing IABP support across various patient ...